T-Cell Subset Linked With Survival After Haplo-HCT for Acute Myeloid Leukemia
Researchers sought to determine whether greater Vδ2-positive T-cell recovery would impact mortality for patients with AML who undergo haplo-HCT.
Diagnosis & Disease Information
Persistent Organ Damage Common One Year After COVID-19
59 percent of individuals had organ impairment at one year; breathlessness, cognitive dysfunction, poor HRQoL also common.
Total Marrow Irradiation With Fludarabine-Melphalan Is a Feasible Conditioning Regimen for Second Allo-SCT
Researchers sought to determine whether IM-TMI combined with fludarabine and melphalan would be a feasible conditioning regimen for patients undergoing allo-SCT.
Mega-Dose Decitabine May Improve Conditioning Before Allo-HSCT in AML
Researchers sought to determine whether a larger dose of decitabine prior to allo-HSCT would improve outcomes in patients with AML.
Iomab-B Enables ASCT in AML Patients Typically Not Eligible for Transplant
Iomab-B plus RIC enables ASCT in a population of AML patients who are not typically eligible for transplant, a phase 3 study suggests.
Chest CT Prior to Stem Cell Transplant Beneficial for Spotting Abnormalities
Patients with abnormal chest CT had worse overall survival, nonrelapse mortality, pulmonary-related death.
Treatment-Related Changes in Physical Function Affect Post-Transplant Survival in Older Adults with AML
Researchers sought to determine whether changes in physical function during intensive chemotherapy would affect post-transplant survival in older adults with AML.
Orca-T Improves Allo-HSCT Outcomes Compared With Historical Control
Researchers sought to determine whether Orca-T could improve relapse and survival outcomes compared with historical controls for patients receiving allo-HSCT.
Reducing IV Crystalloid Fluid Administration May Reduce Risk of Respiratory Failure in Haplo-SCT
Researchers sought to determine whether reducing IV crystalloid fluid administration may decrease the risk of respiratory failure in patients receiving haplo-SCT.
Delayed Immune Recovery Predictive of Worse Overall Survival in Adults Following Allo-HCT
Researchers evaluated whether patients who undergo allo-HCT who have a rapid and robust immune recovery have improved clinical outcomes, including OS rates.
- Loading...
Loading...
Next post in Tandem Meetings 2023
Loading... 
Loading...